Connect with us
German drug-maker Bayer AG is negotiating to buy out partner, Algeta SA.

archive

Bayer to Acquire Partner, Algeta

German drug-maker Bayer AG is negotiating to buy out partner, Algeta SA.

Bayer to Acquire Partner, Algeta (Bloomberg)

German drug-maker Bayer AG is negotiating to buy out partner, Algeta SA. The Norway-based drug company currently shares control of its prostate cancer medicine with Germany‚??s Bayer. Under the proposed deal, Bayer would take full control of the drug, along with a pipeline of experimental radiation therapies. Bayer has offered 14.8 billion kroner (about $2.42 billion) for Algeta, a price which would value Algeta at a 27 percent premium to yesterday‚??s close. Looking ahead, it‚??s unclear what effect the acquisition will have on Bayer‚??s bottom line.

Newsletter Signup.

Sign up to the Human Events newsletter

Written By

Advertisement
Advertisement

TRENDING NOW:

Today a Milkshake, Tomorrow A Brick: Corporate-Backed Political Violence Is Here.

CULTURE

The Lived Experience of Candace Owens.

CULTURE

Buzzfeed Bashes 14-Yr-Old Trump Fan, Celebrates Kids in Drag.

TECH

Al Jazeera: ‘Jews Exploit Holocaust’.

FOREIGN AFFAIRS

Connect
Newsletter Signup.

Sign up to the Human Events newsletter